Vector BioPharma logo

Vector BioPharma

Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.

2

Funding Rounds

$60.0m

Money raised

Overview

Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.

Funding series

Funding Series Analysis

The company Vector BioPharma has raised a total of $60m in funding over 2 rounds.

Key Insights:

  • Vector BioPharma Series A round, August 10, 2022: $30m
  • Vector BioPharma August 2022 Series A Funding Round: $30m
Vector BioPharma logo
Vector BioPharma Series A round, August 10, 2022 $30m
Vector BioPharma logo
Vector BioPharma August 2022 Series A Funding Round $30m

Industries

Vector BioPharma is active in the following industries: